Medical Countermeasures Monoclonal Antibody Shows Broad SARS-CoV-2 Neutralization in Preclinical StudyGlobal Biodefense StaffJuly 8, 2025
Medical Countermeasures New Multi-Epitope Mpox Vaccine Shows Strong Potential in SilicoGlobal Biodefense StaffJuly 8, 2025
Medical Countermeasures Unlocking a New Target Against Crimean-Congo Hemorrhagic Fever VirusGlobal Biodefense StaffJuly 3, 2025
Emory University to Lead Infectious Diseases Clinical Research Consortium Leadership Group Medical Countermeasures January 3, 2020 …
Investigational Drugs Reduce Risk of Death from Ebola Virus Disease Medical Countermeasures December 2, 2019 …
Phase 3 Trial of Modified Vaccinia Ankara as a Smallpox Vaccine Medical Countermeasures November 14, 2019 …
Carb-X Funds Techulon’s Rapidly Adaptable Nano Therapeutic in Fight Against Drug Resistant Bacteria Antimicrobial Resistance November 11, 2019 …
Atriva Therapeutics Reports Results of Phase I Clinical Trial for ATR-002 Antiviral Industry News November 8, 2019 …
Highly Diluted Dose of Ebola Vaccine Shown Effective in Primate Study Medical Countermeasures October 20, 2019 …
Bavarian Nordic Announces Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine Medical Countermeasures October 10, 2019 …
Radiation Poisoning Countermeasure May Also Protect Against MRI Contrast Agent Toxicity CBRNE October 10, 2019 …
BioFactura’s Smallpox Biodefense Therapeutic Awarded $67M BARDA Contract Contracts + Grants September 26, 2019 …
Center for Vaccine Development Awarded up to $201M to Establish Influenza Clinical Core Contracts + Grants September 20, 2019 …
CEPI’s Richard Hatchett: Vaccines ‘Most Powerful Tool Against Infectious Diseases’ Health Security August 26, 2019 …
20 Years of the Strategic National Stockpile: Response History Timeline Medical Countermeasures August 25, 2019 …
Project BioShield: Building a Better Medical Countermeasure Pipeline Contracts + Grants August 5, 2019 …
BARDA Exercises First Option in Transition from BioThrax to AV7909 Anthrax Vaccine Contracts + Grants August 1, 2019 …
Inovio’s Positive First-in-Human MERS Vaccine Results Published in The Lancet Infectious Diseases Medical Countermeasures July 25, 2019 …
